2011
DOI: 10.1016/j.ccr.2011.08.010
|View full text |Cite
|
Sign up to set email alerts
|

Mesenchymal Stem Cells Induce Resistance to Chemotherapy through the Release of Platinum-Induced Fatty Acids

Abstract: The development of resistance to chemotherapy is a major obstacle for lasting effective treatment of cancer. Here, we demonstrate that endogenous mesenchymal stem cells (MSCs) become activated during treatment with platinum analogs and secrete factors that protect tumor cells against a range of chemotherapeutics. Through a metabolomics approach, we identified two distinct platinum-induced polyunsaturated fatty acids (PIFAs), 12-oxo-5,8,10-heptadecatrienoic acid (KHT) and hexadeca-4,7,10,13-tetraenoic acid (16:… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

9
276
0
3

Year Published

2012
2012
2016
2016

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 279 publications
(292 citation statements)
references
References 43 publications
9
276
0
3
Order By: Relevance
“…Indeed, we and others have shown previously that bone marrow-derived MSCs home to and become incorporated into the stroma of developing breast carcinoma xenografts (7)(8)(9). MSCs were also found at elevated levels in the circulation of patients with advanced breast cancer (10) and in the stroma of human primary breast carcinomas (11), observations that are consistent with the systemic mobilization of MSCs by and their recruitment into breast tumors in the clinical setting.…”
supporting
confidence: 84%
“…Indeed, we and others have shown previously that bone marrow-derived MSCs home to and become incorporated into the stroma of developing breast carcinoma xenografts (7)(8)(9). MSCs were also found at elevated levels in the circulation of patients with advanced breast cancer (10) and in the stroma of human primary breast carcinomas (11), observations that are consistent with the systemic mobilization of MSCs by and their recruitment into breast tumors in the clinical setting.…”
supporting
confidence: 84%
“…More recently, a report showed that cis-platinum could induce poly-unsaturated FAs at the tumor sites, which protected tumor cells against a range of chemotherapeutics. 39 This study implies that, in addition to dietary DHA and EPA, activated cells in the tumor microenviroment could also release poly-unsaturated FAs to modify tumor development through GPR120 signaling.…”
Section: Gpr120 Is Induced In Human Crc Tissues and Its Expression Ismentioning
confidence: 85%
“…Unfortunately, we did not measure the rate of incorporation of EPA and DHA in the tumor, but rather their peroxidation product, MDA, and total peroxides. Moreover, the clinical use of FO products or algae is still under debate, especially because Roodhart et al [30] recently reported that the release of specific PUFAs by endogenous mesenchymal stem cells could induce tumor resistance to different chemotherapeutic drugs. Although phospholipases A2, thromboxane synthase, and COX-1 are involved in this chemoresistance [30], our results showed that the modulation of eicosanoid synthesis is not the only mechanism involved and that others have to be taken into account, such as the lipoperoxidative effects on tumor growth.…”
Section: Discussionmentioning
confidence: 99%